Document is current
Any future updates will be listed below
-
Authors
Rioux, Bastien https://orcid.org/0000-0002-0292-259X
McGlasson, Sarah
Forbes, Deborah
Reid, Katy R.
Klingseisen, Anna
Berry, Joe
Dhaun, Neeraj
Ng, Wan Fai
Whiteley, William https://orcid.org/0000-0002-4816-8991
Hunt, David P. J. https://orcid.org/0000-0003-4230-0207
-
Funding
Funding for this research was provided by:
Wellcome Trust (215621/Z/19/Z)
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 5 December 2025
First Online: 27 January 2026
Competing interests
: W.F.N. has undertaken clinical trials and provided consultancy or expert advice in the area of Sjogren disease to the following companies: GlaxoSmithKline, MedImmune, UCB, AbbVie, Takeda, Resolves Therapeutics, Sanofi, Novartis, Bain Capital and Argenx. The other authors declare no competing interests.
